» Articles » PMID: 28063894

Dysregulation of Cytokine Mediated Chemotherapy Induced Cognitive Impairment

Overview
Journal Pharmacol Res
Publisher Elsevier
Specialty Pharmacology
Date 2017 Jan 9
PMID 28063894
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

One of the major complaints patients who survive cancer often make is chemotherapy induced cognitive impairment (CICI), which survivors often call "chemo brain." CICI is a side effect of chemotherapy due to the cytotoxicity and neurotoxicity of anti-cancer drugs causing structural and functional changes in brain, even when drugs that do not cross the blood brain barrier (BBB) are used. Diminished cognitive functions including diminution of learning and memory, concentration and attention, processing speed and executive functions that reduce quality of life and ability to work are common signs and symptoms of CICI. There still is not a clarified and complete mechanism for CICI, but researchers have pointed to several biochemical candidates. Chemotherapy-induced, cytokine-mediated involvement in CICI will be mainly discussed in this review paper with emphasis on different types of cytokines, correlated with BBB and epigenetic changes. Mechanisms of ROS-generating, anti-cancer drugs and their relation to cytokine-mediated CICI will be emphasized.

Citing Articles

Exercise as a Therapeutic Strategy to Improve Cerebrovascular Function and Cognition in Breast Cancer Survivors: A Scoping Review.

Downs T, Whiteside E, Denham J, Mills D, Bliss E J Clin Med. 2025; 13(24).

PMID: 39768764 PMC: 11678850. DOI: 10.3390/jcm13247841.


DNMT3a Downregulation Ttriggered Upregulation of GABA Receptor in the mPFC Promotes Paclitaxel-Induced Pain and Anxiety in Male Mice.

Tian L, Li X, Zhao Y, Yi H, Liu X, Yao R Adv Sci (Weinh). 2024; 12(5):e2407387.

PMID: 39679872 PMC: 11791956. DOI: 10.1002/advs.202407387.


Neurotoxicity of the antineoplastic drugs: "Doxorubicin" as an example.

Fouad G, Rizk M J Mol Histol. 2024; 55(6):1023-1050.

PMID: 39352546 DOI: 10.1007/s10735-024-10247-9.


Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in mice.

Singh A, Ruiz D, Rasheed M, Avery T, Turner D, Abell A bioRxiv. 2024; .

PMID: 38915544 PMC: 11195070. DOI: 10.1101/2024.06.10.598291.


Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.

Duivon M, Lequesne J, Di Meglio A, Pradon C, Vaz-Luis I, Martin A Breast Cancer Res. 2024; 26(1):93.

PMID: 38840166 PMC: 11151649. DOI: 10.1186/s13058-024-01850-5.